Dr. Philip Edward Lammers, MD

Dr. Lammers practices at Baptist Memorial Hospital-Tipton in Covington, Tennessee, part of Baptist Memorial Health Care.

Dr. Lammers' NPI, 1780802330, was assigned on April 20, 2007. Dr. Lammers graduated from Indiana University School of Medicine in 2006. Dr. Lammers holds Tennessee license 45570.

Dr. Lammers' primary practice is Baptist Memorial Hospital-Tipton, at 1995 Highway 51 S, Covington, TN 38019 in Tipton County. The practice phone is (901) 476-2621.

Dr. Lammers' primary practice is Baptist Memorial Hospital-Tipton in Covington, Tennessee, part of Baptist Memorial Health Care. Dr. Lammers is also affiliated with Baptist Memorial Hospital-Memphis. The medical group on file is Baptist Medical Group. Dmand AI also links Dr. Lammers to 3 more hospitals, 4 group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lammers practices, 10 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lammers' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lammers is licensed in Tennessee.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer and multiple myeloma among the conditions Dr. Lammers treats.

CMS data shows 1,675 Medicare services from Dr. Lammers across 9 procedure codes in 2024, for 452 Medicare patients. Medicare paid $92,238 for them.

CMS counts 452 Medicare patients who saw Dr. Lammers in 2024. The largest group is 65 to 74, with 206 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lammers' median patient age at 73, with 75% women.

In 2024, Dr. Lammers wrote 951 Medicare Part D claims for 218 patients. 79% of them were for generic drugs. CMS names the drug for 745 of them, across 23 drugs with 11 or more claims each, at $1,873,348 in total drug cost. In 2023, CMS named 668 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Lammers for performance year 2024, reported as part of a group. Dr. Lammers accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lammers as offering telehealth.

Dmand AI links 41 papers to Dr. Lammers, published from 2011 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Agents. Dr. Lammers has published most often in J Thorac Oncol. Dr. Lammers' most frequent co-authors are Ira Jacobs, MD, David Paul Carbone, MD, PhD and Paul Stuart Appelbaum, MD.

Dmand AI links Dr. Lammers to 10 clinical trials, 5 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Lung Neoplasms, Thoracic Neoplasms and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 9.

CMS Open Payments shows 779 general payments to Dr. Lammers from 68 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. AstraZeneca Pharmaceuticals LP paid the most, $91,805. It also lists 2 research payments totaling $4,711 from 2022 to 2025.

Dr. Lammers graduated from Indiana University School of Medicine in 2006.

Dr. Lammers is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.